GLA
AXSM icon

Great Lakes Advisors’s Axsome Therapeutics AXSM Stock Holding History

Great Lakes Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Hold
6,730
– – 0.01% 449
2026
Q1 		$1.14M Sell
6,730
-35
-0.5% -$6.04K 0.01% 497
2025
Q4 		$1.24M Buy
6,765
+89
+1% +$12.4K 0.01% 494
2025
Q3 		$811K Buy
6,676
+306
+5% +$34.5K 0.01% 547
2025
Q2 		$665K Sell
6,370
-823
-11% -$87.1K 0.01% 575
2025
Q1 		$839K Sell
7,193
-6,315
-47% -$719K 0.01% 529
2024
Q4 		$1.14M Sell
13,508
-3,220
-19% -$296K 0.01% 563
2024
Q3 		$1.5M Buy
16,728
+4,587
+38% +$400K 0.01% 526
2024
Q2 		$977K Buy
+12,141
New +$899K 0.01% 580

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Great Lakes Advisors's AXSM Position: Q2 2026 in Review

Great Lakes Advisors held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 6,730 shares worth $1.65M. The position accounts for 0.01% of the portfolio, ranked #449.

Great Lakes Advisors first reported a position in AXSM in Q2 2024 and has held it in 9 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Great Lakes Advisors held 6,730 shares of Axsome Therapeutics worth $1.65M as of Q2 2026.
  • Great Lakes Advisors left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up 0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #449 holding.
  • Great Lakes Advisors first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.